key: cord-0878974-d97qc35a
authors: Tse, Herman; Wong, Sally Cheuk-Ying; Ip, Ka-Fai; Cheng, Vincent Chi-Chung; To, Kelvin Kai-Wang; Lung, David Christopher; Choi, Garnet Kwan-Yue
title: Genome Sequences of Three SARS-CoV-2 ORF7a Deletion Variants Obtained from Patients in Hong Kong
date: 2021-04-15
journal: Microbiol Resour Announc
DOI: 10.1128/mra.00251-21
sha: 828ecb2e7d4950d8e791386603f4039b96937d26
doc_id: 878974
cord_uid: d97qc35a

We report the genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains from the clinical samples of three coronavirus disease 2019 (COVID-19) patients in Hong Kong. All the genome sequences showed a 370-nucleotide deletion resulting in the complete loss of ORF7a.

S evere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel member of the genus Betacoronavirus in the family Coronaviridae and the causative agent of coronavirus disease 2019 (COVID-19). More than 100 million cases of infection had been reported globally by the end of January 2021 (1) . In this report, we present the genome sequences of SARS-CoV-2 strains from 3 COVID-19 patients in Hong Kong obtained during investigation of a local cluster in mid-January 2021. The study protocol was approved by the institutional review board of The University of Hong Kong/ Hospital Authority Hong Kong West Cluster (UW 13-372). Saliva specimens were collected by patients as described previously (2) . Total nucleic acid extraction was performed using the MagNA Pure 96 DNA and viral NA small-volume kit (Roche, Switzerland). Tiling PCR for specific preamplification of the SARS-CoV-2 genome was performed using the ARTIC v3 primer set (https://github.com/ artic-network/artic-ncov2019/tree/master/primer_schemes/nCoV-2019/V3) according to the specified protocol (https://www.protocols.io/view/ncov-2019-sequencing-protocol -v3-locost-bh42j8ye). Library preparation for multiplexed sequencing, with up to 32 samples per run, was performed using IDT for Illumina DNA/RNA unique dual (UD) indexes and the Illumina DNA prep kit (California, USA). Sequencing of the pooled library was performed on an iSeq 100 sequencer (Illumina) to obtain paired-end 150bp reads.

Fastp version 0.21.0 (3) was used for quality control and preprocessing of demultiplexed read data. Subsequent processing was performed according to the Utah Department of Health ARTIC/Illumina Bioinformatic Workflow (https://github.com/CDCgov/ SARS-CoV-2_Sequencing/tree/master/protocols/BFX-UT_ARTIC_Illumina), except for the use of bwa-mem2 instead of bwa for mapping reads. Briefly, reads were mapped to a reference SARS-CoV-2 genome sequence (GenBank accession number MN908947.3) with bwa-mem2 version 2.0 (4), and primer trimming was performed using iVar version 1.3 (5) . Variant calling and consensus sequence generation were performed using SAMtools version 1.10 (6). The genome assembly was visualized and examined using Tablet version 1.20.12.24 (7) .

The sequencing statistics and genomic features of the genome assemblies are summarized in Table 1 . Notably, the present sequences contained a 370-nucleotide deletion spanning positions 27387 to 27756 of the reference SARS-CoV-2 genome. This major deletion was confirmed independently by long-range PCR and Sanger sequencing (with primers 59-AACTCGTAATCGGAGCTGTGA-39 and 59-TGTCATTCTCCTAAGAAG CTATTAAA-39). As a result, the entire ORF7a and the original stop codon for ORF6 were lost. The latter resulted in an extension of the Orf6 protein by 2 amino acids. Furthermore, ORF7b was potentially extended in the 59 direction by 27 nucleotides due to the occurrence of an in-frame start codon.

Various major ORF7a deletions, sometimes alongside other major deletions, have been reported previously (8) (9) (10) . The repeated reemergence of ORF7a deletion variants may suggest that the accessory protein could impose a fitness cost that exceeds the benefits of its canonical function in certain situations.

Data availability. These genome sequences were deposited in GenBank under accession numbers MW691225, MW691226, and MW691227. The raw reads were deposited in SRA under accession numbers SRR13775065, SRR13775066, and SRR13775067. a Nucleotide (and amino acid) substitutions common to all three strains (mapped against the genome sequence of reference SARS-CoV-2 strain Wuhan-Hu-1; GenBank accession number MN908947.3) include C241T, C3037T, C4276T, C5339T (nsp3 P874S), C5812T, C6027T (nsp3 P1103L), C10039T, C10456T, C14408T (nsp12 P323L), C18877T, C19572T, C20844T, C22444T, T22882G (spike N440K), A23403G (spike D614G), G23587T (spike Q675H), G25563T (orf3a Q57H), G25785T (orf3a W131C), C26625T, C26735T, G28690T (nucleocapsid L139F), and C28854T (nucleocapsid S194L). The nucleotide substitution is synonymous or in a noncoding region if no accompanying amino acid substitution is shown. b When mapped against the genome sequence of reference SARS-CoV-2 strain Wuhan-Hu-1 (GenBank accession number MN908947.3). c The nucleotide substitution is synonymous or in a noncoding region if no accompanying amino acid substitution is shown.

Weekly epidemiological update-2

Posterior oropharyngeal saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

fastp: an ultra-fast all-in-one FASTQ preprocessor

Efficient architecture-aware acceleration of BWA-MEM for multicore systems

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data

Using Tablet for visual exploration of second-generation sequencing data

Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates

An 81-nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona

Emergence of a severe acute respiratory syndrome coronavirus 2 virus variant with novel genomic architecture in Hong Kong

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. We thank the Hospital Authority and the Food and Health Bureau for their administrative and policy support.